Treatment of Tourette's Syndrome in Children
The recommended first-line treatment for Tourette's syndrome in children is Comprehensive Behavioral Intervention for Tics (CBIT), which has demonstrated significant efficacy and durability with minimal side effects compared to pharmacological approaches. 1, 2
Treatment Algorithm
First-Line Treatment: Behavioral Interventions
- CBIT combines habit reversal training (HRT) and functional intervention to address the urge-tic relationship and identify environmental triggers 1
- CBIT has been designated as first-line treatment by American Academy of Neurology, European and Canadian medical academies 1
- Demonstrated efficacy in large-scale randomized controlled trials with 248 participants aged 8-69 years 1
- Produces significant reduction in tic severity compared to supportive therapy (effect size = 0.68) 3
- Treatment benefits are durable, with 87% of responders maintaining improvement at 6-month follow-up 3
- Can be delivered effectively via individual face-to-face sessions, videoconferencing, or internet-based programs 2
Second-Line Treatment: Pharmacological Options
When behavioral therapy is insufficient or unavailable, medication may be considered:
Alpha-2 adrenergic agonists (clonidine, guanfacine)
Antipsychotic medications
Important Clinical Considerations
- Treatment should be initiated only when tics cause functional impairment, social problems, or significant distress 5
- For mild tics without functional impairment, reassurance and monitoring may be sufficient 5
- Comorbidities are common and may require separate treatment:
Common Pitfalls to Avoid
- Delaying diagnosis by misinterpreting tics as habit behaviors 6
- Initiating pharmacotherapy before trying behavioral interventions 1, 2
- Failing to address common comorbidities that may exacerbate tic symptoms 6
- Concerns about tic suppression causing "rebound" effects are unfounded; behavioral interventions are safe 1
Advanced Treatment Options
- Deep brain stimulation (DBS) should be reserved only for severe, treatment-refractory cases with significant functional impairment 7
- DBS has shown promising results in treatment-resistant cases, with approximately 97% of patients showing improvement in published studies 7
- DBS should only be considered after failure of standard pharmacological and behavioral therapies 7